Chonnam Med J.  2007 Apr;43(1):25-32.

Methylenetetrahydrofolate Reductase Gene Single Nucleotide Polymorphism in Korean Population with Ischemic Stroke

Affiliations
  • 1Department of Neurology, Gwangju Hospital, Gwangju, Korea.
  • 2Chonnam National University Medical School and Chonnam National University Research Institute of Medical Science, Gwangju, Korea. mkkim@chonnam.ac.kr

Abstract

The identification of novel markers of stroke risk is of key importance, both for risk prediction and potential modification to reduce future events. Recently, a mutation (C677T) in the methylenetetrahydrofolate reductase (MTHFR) gene was identified to cause elevation of the plasma homocysteine level that is associated with increased risk of vascular disorders. The authors aimed to elucidate the genetic contribution of MTHFR C677T single nucleotide polymorphism (SNP) to ischemic stroke in Korean population. A total of 332 individuals with ischemic stroke and 110 controls without any evidence of having brain lesion were enrolled. To assess the risk of ischemic stroke, clinical characteristics and MTHFR C677T genotypes of all participants were compared. Genotyping of MTHFR C677T SNP was performed for each individual using PCR amplification and direct sequencing in both strands. The frequency of the mutant heterozygote (677CT) and homozygote for C677T SNP in control subjects were 55.5 and 13.6%, respectively. The mean plasma homocysteine level was significantly higher (p<0.001) in ischemic stroke patients group (11.4+/-4.6 micronmol/L) than in control group (9.4+/-3.3micronmol/L). Also, the plasma homocysteine levels were significantly increased with the 677T allele in a dose-dependent manner (p<0.001). Despite the clear association between MTHFR C677T genotypes and elevated homocysteine level, no definite association between MTHFR C677T genotypes and ischemic stroke was evident in Korean population. Elevated plasma homocysteine level is associated with increased risk of ischemic stroke and MTHFR 677T allele may be an independent risk factor for elevated plasma homocysteine level in Korean population.

Keyword

Homocysteine; Methylenetetrahydrofolate reductase; Ischemic stroke

MeSH Terms

Alleles
Brain
Genotype
Heterozygote
Homocysteine
Homozygote
Humans
Methylenetetrahydrofolate Reductase (NADPH2)*
Plasma
Polymerase Chain Reaction
Polymorphism, Single Nucleotide*
Risk Factors
Stroke*
Homocysteine
Methylenetetrahydrofolate Reductase (NADPH2)
Full Text Links
  • CMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr